Sign up
Quantellect · Congress · Trade Detail
NASDAQ: BIIBBiogen Inc
RepublicanHouse

Mike Kelly bought Biogen Inc (NASDAQ: BIIB)

Mike Kelly (R-PA), a U.S. Representative, has disclosed 2 trades in Biogen Inc (BIIB) since 2016, 1 purchase and 1 sale, worth an estimated $16K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a purchase: Mike Kelly bought $1,001 - $15,000 of Biogen Inc (NASDAQ: BIIB) on August 4, 2016. Since that trade, BIIB is down -33.90% against the S&P 500 up +301.32%, an outperformance of -335.22%.

Across these filings, Mike Kelly has been a balanced trader of BIIB (a buy-to-sell ratio of 1.00). The most recent disclosed BIIB transaction shown was dated March 9, 2019. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BIIB trades
2
Disclosed Vol
$16K
Buys
1
50%
Sells
1
50%
Buy / Sell
1.00
ratio
First → Last
2016–2019

Mike Kelly's BIIB trades vs the price

BIIB is down -33.90% since Mike Kelly bought on August 4, 2016, versus +301.32% for the S&P 500.

Performance since this trade

Price change since trade
-33.90%
S&P 500 change since trade
+301.32%
Outperformance vs S&P 500
-335.22%

All Mike Kelly BIIB trades

TradedTypeSizeReturnEst. profit
March 9, 2019SELL$307.93-32.47%
August 4, 2016BUY$314.56-33.90%-$3K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

Mike Kelly & BIIB trading FAQ

Is it legal for Mike Kelly to trade Biogen Inc (BIIB) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Biogen Inc (BIIB), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did Mike Kelly buy BIIB?

Mike Kelly disclosed a purchase of $1,001 - $15,000 of Biogen Inc (BIIB) on August 4, 2016, according to public STOCK Act filings.

How has BIIB performed since Mike Kelly's trade?

Since Mike Kelly bought BIIB on August 4, 2016, the stock is down -33.90%, versus +301.32% for the S&P 500 over the same period, an outperformance of -335.22%.

How many times has Mike Kelly traded BIIB?

Mike Kelly has disclosed 2 BIIB trades since 2016 (1 purchase and 1 sale). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BIIB trades?

Quantellect tracks every disclosed congressional trade in Biogen Inc (BIIB) on the Biogen Inc congressional trading page, which aggregates filings across all members of Congress.

Mike Kelly's BIIB tradesAll congressional filings for Biogen IncMike Kelly's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.